Digital health case study Biopharma

Benchmarking Digital Health partnerships

Client context: Benchmarking Digital Health partnerships

Strategic question

Our client, a leading global biopharma, wanted monitor how biopharma is investing and operating in Digital Health across their value chain, to better support its own Digital Health portfolio strategy.

Outcomes

Galen Growth mapped out the Digital Health partnerships of their top 25 competitors, across 15 countries and two therapeutic areas. We then developed a relevance scoring methodology, driven by our proprietary venture signals which enabled the prioritising of 500+ relevant ventures for consideration as a partner for our client.

How Galen Growth helped

Our client, a leading global biopharma, wanted monitor how biopharma is investing and operating in Digital Health across their value chain, to better support its own Digital Health portfolio strategy.

Methodology

Define Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map Identify relevant ventures, markets, competitors, partnerships, categories, and evidence signals.
Assess Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide Translate findings into a shortlist, benchmark, market view, or portfolio recommendation.

Overview

Category

Stage

Total Funding

GGA Score

powered by